BioSpace News Archive

The OSIC Pulmonary Fibrosis Progression Will Challenge the World’s Brightest Data Science Minds to Predict Lung Function Decline by Using Machine Learning

Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBI” and the “Company”) today announced that the Company will host a teleconference to discuss its First Quarter 2020 financial results and to provide a business update,

EOS imaging, a leader in 2D/3D orthopedic medical imaging and software solutions for 3D anatomical modeling and surgical planning, announces that it has made available to the public an English translation of its Annual Financial Report as at December 31, 2019.

A just published peer-reviewed study from Henry Ford Health System showed that the death rate of hospitalized patients who received hydroxychloroquine (HCQ) was cut in half, and there were no serious heart abnormalities.

Company Seeks to Partner with Health Systems to Unlock Value in Rehabilitation Operations, Promote Continuity of Care, and Improve Patient Outcomes

Dr. Leslie Fish, recently placed his 200th implant using the only FDA cleared Dental Surgical Robotics System, Yomi. This achievement makes him the most experienced Dental Robotics Surgeon in the world.

LaunchPad Medical, Inc. announced that it has received approval from the Medicines and Healthcare products Regulatory Agency in the United Kingdom to start a 15-patient pilot clinical study to examine the safety and efficacy of Tetranite®,

Orthopaedic surgeons at Crystal Clinic Orthopaedic Center are at the forefront of developing advanced, minimally invasive techniques for patients and providing training to other surgeons around the globe in their use.

Today, the U.S. Food and Drug Administration approved Inqovi (decitabine and cedazuridine) tablets for treatment of adult patients with myelodysplastic syndromes (MDS) and chronic myelomonocytic leukemia (CMML).

Aesculap Implant Systems, LLC today announced that National Imaging Associates (NIA), a Magellan Health Company, has updated its “Clinical Guidelines for Medical Necessity for Musculoskeletal and Surgery” to include a medical necessity recommendation for Lumbar Total Disc Replacement (TDR), including the latest generation activL® Artificial Disc.